The pharmacology of tacrine at N-methyl-d-aspartate receptors

[1]  T. B. Ferguson,et al.  The effect of some acridine compounds on the growth and respiration of E. coli. , 1946, The Journal of pharmacology and experimental therapeutics.

[2]  A. Albert.  The acridines. Their preparation, physical, chemical and biological properties and uses. , 1951 .

[3]  A. Shulman,et al.  Morphine Antagonists , 1955, Nature.

[4]  M. Barber,et al.  ANTIBIOTIC-RESISTANT STAPHYLOCOCCAL INFECTIONS , 1955 .

[5]  F. Shaw,et al.  TETRAHYDROAMINACRIN AS A DECURARISING AGENT , 1958, The Journal of pharmacy and pharmacology.

[6]  S. Gershon.  Blocking Effect of Tetrahydroaminacrin on a New Psychotomimetic Agent , 1960, Nature.

[7]  F. Shaw,et al.  Treatment of Intractable Pain with Morphine and Tetrahydroaminacrine , 1961, British medical journal.

[8]  K. Mccaul,et al.  Suxamethonium "extension" by tetrahydroaminacrine. , 1962, British journal of anaesthesia.

[9]  S. Gershon,et al.  EXPERIMENTAL ANTICHOLINERGIC PSYCHOTOMIMETICS: ANTAGONISM OF YOHIMBINE AND TACRINE (THA). , 1964, Medicina experimentalis : International journal of experimental medicine.

[10]  J. W. Amshey,et al.  A Screening Program for Selective Inhibitors of the Phosphorylation of Acetylcholinesterase. , 1973 .

[11]  P. Jannetta,et al.  Ketamine-induced postanesthetic delirium attenuated by tetrahydroaminoacridine. , 1974, Experimental neurology.

[12]  M. Albin,et al.  Tetrahydroaminoacridine antagonism to narcotic addiction , 1975, Experimental Neurology.

[13]  R. Baldessarini,et al.  Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. , 1975, Archives of general psychiatry.

[14]  G M Steinberg,et al.  A hydrophobic binding site in acetylcholinesterase. , 1975, Journal of medicinal chemistry.

[15]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[16]  J. Patočka,et al.  Kinetics of inhibition of cholinesterases by 1,2,3,4-tetrahydro-9-aminoacridine in vitro , 1976 .

[17]  K. Kaufman,et al.  THA--a review of the literature and its use in treatment of five overdose patients. , 1980, Clinical toxicology.

[18]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[19]  J. Penney,et al.  Tetrahydro-9-aminoacridine (THA) interacts with the phencyclidine (PCP) receptor site , 1988, Neuroscience Letters.

[20]  D. Choi,et al.  Tetrahydroaminoacridine selectively attenuates NMDA receptor-mediated neurotoxicity. , 1988, European journal of pharmacology.

[21]  E. Giacobini,et al.  The cholinergic receptor system of the human brain: neurochemical and pharmacological aspects in aging and Alzheimer. , 1989, Progress in brain research.

[22]  R. Dawson.  Tacrine slows the rate of ageing of sarin-inhibited acetylcholinesterase , 1989, Neuroscience Letters.

[23]  S. E. Freeman,et al.  Tacrine: A pharmacological review , 1991, Progress in Neurobiology.

[24]  M. Rogawski,et al.  Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons. , 1991, Molecular pharmacology.

[25]  Putative mechanisms of action of tacrine in Alzheimer's disease , 1992 .

[26]  M. Szilágyi,et al.  Interaction of tacrine at M1 and M2 cholinoceptors in guinea pig brain. , 1993, Pharmacology.

[27]  W. Carlezon,et al.  D-cycloserine attenuates scopolamine-induced learning and memory deficits in rats. , 1993, Behavioral and neural biology.

[28]  E K Perry,et al.  Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. , 1993, Brain research. Developmental brain research.

[29]  Tetrahydroaminoacridine attenuates dizocilpine-induced behavioural changes , 1993, Behavioural Brain Research.

[30]  T. Dawson,et al.  Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  I. Sharonova,et al.  Tetrahydroaminoacridine blocks and prolongs NMDA receptor-mediated responses in a voltage-dependent manner. , 1994, European journal of pharmacology.

[32]  E. Albuquerque,et al.  Dynamics of the actions of tetrahydro-9-aminoacridine and 9-aminoacridine on glutamatergic currents: concentration-jump studies in cultured rat hippocampal neurons. , 1994, The Journal of pharmacology and experimental therapeutics.

[33]  D. Lahiri.  Reversibility of the effect of tacrine on the secretion of the β-amyloid precursor protein in cultured cells , 1994, Neuroscience Letters.

[34]  E. Albuquerque,et al.  9-Aminoacridines act at a site different from that for Mg2+ in blockade of the N-methyl-D-aspartate receptor channel. , 1994, Molecular pharmacology.

[35]  A. Lindsay,et al.  Kainate injury to cultured basal forebrain cholinergic neurons is Ca2+ dependent , 1994, Neuroreport.

[36]  D. Choi,et al.  Basal forebrain cholinergic neurons are selectively vulnerable to AMPA/kainate receptor-mediated neurotoxicity , 1994, Neuroscience.

[37]  J. Soares,et al.  THA--historical aspects, review of pharmacological properties and therapeutic effects. , 1995, Dementia.

[38]  M. M'Harzi,et al.  Antagonism of scopolamine-induced memory impairments in rats by the muscarinic agonist RU 35 926 (CI-979) , 1995, Pharmacology Biochemistry and Behavior.

[39]  T. Aigner.  Pharmacology of memory: cholinergic—glutamatergic interactions , 1995, Current Opinion in Neurobiology.

[40]  M. Ohno,et al.  D-cycloserine, a glycine site agonist, reverses working memory failure by hippocampal muscarinic receptor blockade in rats. , 1996, European Journal of Pharmacology.

[41]  M. Kistler,et al.  Cholinergic improvement of a naturally-occurring memory deficit in the young rat , 1996, Brain Research.

[42]  D. Braida,et al.  An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. , 1996, European journal of pharmacology.

[43]  T. Aigner,et al.  D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys. , 1996, The Journal of pharmacology and experimental therapeutics.

[44]  V. Bigl,et al.  Repeated administration of tacrine to normal rats: Effects on cholinergic, glutamatergic, and GABAergic receptor subtypes in rat brain using receptor autoradiography , 1997, Neurochemistry International.

[45]  S. Harkins,et al.  Tacrine treatment in Alzheimer's disease enhances cerebral blood flow and mental status and decreases caregiver suffering. , 1997, Annals of the New York Academy of Sciences.

[46]  P. Riekkinen,et al.  Tetrahydroaminoacridine and D-cycloserine stimulate acquisition of water maze spatial navigation in aged rats. , 1998, European journal of pharmacology.

[47]  J. Olney,et al.  Glumate receptor dysfunction and Alzheimer's disease. , 1998, Restorative neurology and neuroscience.

[48]  X. Tang,et al.  Comparative Studies of Huperzine A, E2020, and Tacrine on Behavior and Cholinesterase Activities , 1998, Pharmacology Biochemistry and Behavior.

[49]  X. Tang,et al.  Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine. , 1998, European journal of pharmacology.

[50]  E. Halgren,et al.  Reduction of motoric agitation and restlessness by AF102B and tacrine in the macaque. , 1999, The Journal of neuropsychiatry and clinical neurosciences.

[51]  E. Halgren,et al.  Divided attention-enhancing effects of AF102B and THA in aging monkeys , 1999, Psychopharmacology.

[52]  E. Perry,et al.  Acetylcholine in mind: a neurotransmitter correlate of consciousness? , 1999, Trends in Neurosciences.

[53]  G. Hu,et al.  Comparison of the effects of cholinesterase inhibitors on [3H]MK-801 binding in rat cerebral cortex , 1999, Neuroscience Letters.

[54]  M. Callahan.  Combining tacrine with milameline reverses a scopolamine-induced impairment of continuous performance in rhesus monkeys , 1999, Psychopharmacology.

[55]  P. Carlier,et al.  Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor. , 1999, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[56]  A. Chiba,et al.  Cognitive functions of the basal forebrain , 1999, Current Opinion in Neurobiology.

[57]  Yifan Han,et al.  Learning deficits induced by 4 belladonna alkaloids are preferentially attenuated by tacrine. , 2000, Acta pharmacologica Sinica.

[58]  M. Parent,et al.  Increasing acetylcholine levels in the hippocampus or entorhinal cortex reverses the impairing effects of septal GABA receptor activation on spontaneous alternation. , 2000, Learning & memory.

[59]  P. Riekkinen,et al.  Pre-training blocks the improving effect of tetrahydroaminoacridine and D-cycloserine on spatial navigation performance in aged rats. , 2000, European journal of pharmacology.

[60]  H. Ogura,et al.  Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. , 2000, Methods and findings in experimental and clinical pharmacology.

[61]  J Korf,et al.  β‐Amyloid neurotoxicity is mediated by a glutamate‐triggered excitotoxic cascade in rat nucleus basalis , 2000, The European journal of neuroscience.

[62]  Yi-fan Han,et al.  Bis(7)-tacrine, a promising anti-Alzheimer's agent, reduces hydrogen peroxide-induced injury in rat pheochromocytoma cells: comparison with tacrine , 2000, Neuroscience Letters.

[63]  M. Parent,et al.  Infusions of physostigmine into the hippocampus or the entorhinal cortex attenuate avoidance retention deficits produced by intra-septal infusions of the GABA agonist muscimol , 2001, Brain Research.

[64]  J. Cai,et al.  Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys. , 2001, European journal of pharmacology.

[65]  A. Nordberg,et al.  Chronic treatments with tacrine and (−)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat , 2002, Journal of Neural Transmission.

[66]  Rui Wang,et al.  Tacrine attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells. , 2002, Brain research. Molecular brain research.

[67]  T. Myhrer,et al.  Effects of scopolamine and d-cycloserine on non-spatial reference memory in rats , 2002, Behavioural Brain Research.

[68]  F. Colpaert,et al.  Tacrine-scopolamine interactions on state-dependent retrieval , 2003, Psychopharmacology.

[69]  Eric Halgren,et al.  Reduction in distractibility with AF102B and THA in the macaque , 2003, Pharmacology Biochemistry and Behavior.

[70]  J. J. Chrobak,et al.  Within-subject memory decline in middle-aged rats: effects of intraseptal tacrine , 2004, Neurobiology of Aging.

[71]  J. J. Chrobak,et al.  Intraseptal tacrine can enhance memory in cognitively impaired young rats , 2004, Neuroreport.

[72]  D. Gambi,et al.  Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines , 2004, Journal of Neuroimmunology.

[73]  A. Enz,et al.  Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain , 2004, Neuropharmacology.

[74]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[75]  J. J. Chrobak,et al.  Intraseptal tacrine-induced disruptions of spatial memory performance , 2005, Behavioural Brain Research.

[76]  A. Akaike,et al.  Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade , 2006, Neuropharmacology.

[77]  Hang Dong,et al.  Evaluation of acute tacrine treatment on passive-avoidance response, open-field behavior, and toxicity in 17- and 30-day-old mice , 2006, Pharmacology Biochemistry and Behavior.

[78]  H. Xue,et al.  Effects of a memory enhancing peptide on cognitive abilities of brain‐lesioned mice: additivity with huperzine A and relative potency to tacrine , 2006, Journal of peptide science : an official publication of the European Peptide Society.

[79]  Y. Pang,et al.  Bis(7)‐tacrine attenuates β amyloid‐induced neuronal apoptosis by regulating L‐type calcium channels , 2006, Journal of neurochemistry.

[80]  W. Markesbery,et al.  Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease , 2006, Neurobiology of Aging.

[81]  A. Akaike,et al.  Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity. , 2006, European journal of pharmacology.

[82]  Wei Zhang,et al.  Novel dimeric bis(7)-tacrine proton-dependently inhibits NMDA-activated currents. , 2007, Biochemical and biophysical research communications.

[83]  N. Lee,et al.  Evaluation of acute bis(7)-tacrine treatment on behavioral functions in 17-day-old and 30-day-old mice, with attention to drug toxicity , 2007, Pharmacology Biochemistry and Behavior.

[84]  Ann Marie Craig,et al.  NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo , 2007, The Journal of Neuroscience.

[85]  Maurizio Recanatini,et al.  Multi-target-directed ligands to combat neurodegenerative diseases. , 2008, Journal of medicinal chemistry.

[86]  Xiaoliang Wang,et al.  Bis(7)-tacrine, a promising anti-Alzheimer's dimer, affords dose- and time-dependent neuroprotection against transient focal cerebral ischemia , 2008, Neuroscience Letters.

[87]  Y. Pang,et al.  Inhibition of NMDA-gated ion channels by bis(7)-tacrine: Whole-cell and single-channel studies , 2008, Neuropharmacology.

[88]  R. Agrawal,et al.  Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. , 2008, European journal of pharmacology.

[89]  Wenming Li,et al.  Mecamylamine prevents neuronal apoptosis induced by glutamate and low potassium via differential anticholinergic-independent mechanisms , 2008, Neuropharmacology.

[90]  Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors. , 2008, Biochemical and biophysical research communications.

[91]  Jia-hua Fang,et al.  Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage , 2010, BMC Neuroscience.

[92]  Hang Dong,et al.  Comparison Studies of Tacrine and Bis(7)-Tacrine on the Suppression of Scopolamine-Induced Behavioral Changes and Inhibition of Acetylcholinesterase in Mice , 2009, Pharmacology.

[93]  V. Tumiatti,et al.  Tacrine derivatives and Alzheimer's disease. , 2010, Current medicinal chemistry.

[94]  B. Sabatini,et al.  M1 Muscarinic Receptors Boost Synaptic Potentials and Calcium Influx in Dendritic Spines by Inhibiting Postsynaptic SK Channels , 2010, Neuron.

[95]  Alok Kumar,et al.  Cell death mechanisms in the early stages of acute glutamate neurotoxicity , 2010, Neuroscience Research.

[96]  R. Dingledine,et al.  Glutamate Receptor Ion Channels: Structure, Regulation, and Function , 2010, Pharmacological Reviews.

[97]  R. Vetreno,et al.  Differential effects of systemic and intraseptal administration of the acetylcholinesterase inhibitor tacrine on the recovery of spatial behavior in an animal model of diencephalic amnesia. , 2010, European journal of pharmacology.

[98]  Facilitation of Long-Term Potentiation by Muscarinic M1 Receptors Is Mediated by Inhibition of SK Channels , 2010, Neuron.

[99]  Yi-fan Han,et al.  Tacrine treatment at high dose suppresses the recognition memory in juvenile and adult mice with attention to hepatotoxicity. , 2011, Basic & clinical pharmacology & toxicology.

[100]  P. Kristian,et al.  Neuroactive Multifunctional Tacrine Congeners with Cholinesterase, Anti-Amyloid Aggregation and Neuroprotective Properties , 2011, Pharmaceuticals.

[101]  Christopher P. Chen,et al.  Pharmacokinetic and Pharmacodynamic Properties of Cholinesterase Inhibitors Donepezil, Tacrine, and Galantamine in Aged and Young Lister Hooded Rats , 2011, Drug Metabolism and Disposition.

[102]  M. Pohanka,et al.  Tacrine is implicated in oxidative stress in the laboratory guinea pig model. , 2012, Neuro endocrinology letters.

[103]  R. McShane,et al.  Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review , 2012, BMJ Open.

[104]  K. Kuča,et al.  7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment — Synthesis, Biological Evaluation and Molecular Modeling Studies , 2013, Molecules.

[105]  P. Cristóbal-Narváez,et al.  D-cycloserine in Prelimbic Cortex Reverses Scopolamine-Induced Deficits in Olfactory Memory in Rats , 2013, PloS one.

[106]  K. Kuča,et al.  A resurrection of 7-MEOTA: a comparison with tacrine. , 2013, Current Alzheimer research.

[107]  R. Petralia,et al.  ER to synapse trafficking of NMDA receptors , 2014, Front. Cell. Neurosci..

[108]  K. Kuča,et al.  7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies. , 2014, European journal of medicinal chemistry.

[109]  M. Martí-Nicolovius,et al.  d-cycloserine prevents relational memory deficits and suppression of long-term potentiation induced by scopolamine in the hippocampus , 2014, European Neuropsychopharmacology.

[110]  Hiro Furukawa,et al.  Crystal structure of a heterotetrameric NMDA receptor ion channel , 2014, Science.

[111]  V. Andrisano,et al.  Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects. , 2014, Journal of medicinal chemistry.

[112]  M. Balog,et al.  Synthesis and functional survey of new Tacrine analogs modified with nitroxides or their precursors. , 2014, European journal of medicinal chemistry.

[113]  M. Regan,et al.  A structural biology perspective on NMDA receptor pharmacology and function. , 2015, Current opinion in structural biology.

[114]  K. Kuča,et al.  7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment , 2015, Molecules.

[115]  D. Lodge,et al.  Ketamine and phencyclidine: the good, the bad and the unexpected , 2015, British journal of pharmacology.

[116]  K. Kuča,et al.  Tacrine-Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity. , 2015, Journal of medicinal chemistry.

[117]  Design, synthesis and in vitro testing of 7-methoxytacrine-amantadine analogues: a novel cholinesterase inhibitors for the treatment of Alzheimer’s disease , 2015, Medicinal Chemistry Research.

[118]  V. Andrisano,et al.  Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease. , 2016, European journal of medicinal chemistry.

[119]  Christian C. Felder,et al.  Activation of Muscarinic M1 Acetylcholine Receptors Induces Long-Term Potentiation in the Hippocampus , 2015, Cerebral cortex.